(Q30514653)

English

VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells (English)
Paul Sirajuddin
Frank Suprynowicz
Venkata M Yenugonda
Milton L Brown
Jeffrey A Toretsky
Tobey J MacDonald
Olga Rodriguez
Robert I Glazer
Richard Schlegel
Chris Albanese

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit